Glenview Capital and Novo Holdings led a $245m Series D funding round in Quanta Dialysis.

Glenview Capital, a capital manager, and Novo Holdings, a life science investor, led a $245m Series D funding round in Quanta Dialysis, a medical technology company. Additional Investors include BlackRock, Eldridge, Sands Capital, Millennium Management, Monashee Investment, Puhua Capital, Segulah Medical, Ancora, Orlando Health, Wellington Partners, btov, Seroba Life Sciences and The Grands. “Quanta’s innovative cartridge-based system is compact, simple, and powerful and provides tremendous value and treatment flexibility for providers and patients across an omni-channel delivery chain, from dedicated dialysis centers, acute care hospitals, and increasingly moving into the home. With this growth capital, Quanta has the resources to drive improved patient outcomes and convenience while accelerating market penetration and scale," Lee Hathaway, Glenview Capital Partner.